Urinary eicosanoids - novel biomarkers in T2-low severe asthma - Milan 2023

Phenotypes and biomarkers in asthma

Chair(s): Fabio L. M. Ricciardolo

Session type: Oral presentation

Urinary eicosanoids - novel biomarkers in T2-low severe asthma

Matthew Chad Eastwood

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Seasonal variation in nasal epithelium gene expression

Tatiana Karp

Replay

Poster

Abstract

Slides

Impact of ERS/ATS 2022 BDR criteria on the characteristics of patients with airways disease

Rod Hughes

Replay

Poster

Abstract

Slides

Cluster analysis to identify distinct clinical asthma phenotypes within ATLANTIS

Pauline Kuks

Replay

Abstract

Slides

How respiratory symptoms impact asthma-related quality of life in severe asthmatics

Gilles Louis

Replay

Abstract

Slides

Patient-centred composite index for assessment of response to biological therapy for adult severe asthma.

Ekateirina Khaleva

Replay

Poster

Abstract

Slides

Longitudinal assessment of glucocorticoid toxicity in biologics treated severe asthma

Pamela Jane Mcdowell

Replay

Poster

Abstract

Slides

Associations of imaging biomarkers with physiological markers of small airways dysfunction in asthma in the ATLANTIS study.

Franz Aaron Clemeno

Replay

Poster

Abstract

Slides

Eosinophil-derived neurotoxin determinants and reference values in a middle-aged Swedish population

Suneela Zaigham

Replay

Poster

Abstract

Slides

Urinary eicosanoids - novel biomarkers in T2-low severe asthma

Matthew Chad Eastwood

Replay

Poster

Abstract

Slides

Identification of neutrophilic asthma via the ratio of sphingolipids to glucocorticoids

Craig Wheelock

Replay

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}